Profit taking weighs down Cyclacel

Profit taking weighed down shares of Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) 31 cents to close at $0.72.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.